Abstract: The invention relates to MIC-1 compounds. More specifically it relates to compounds comprising a MIC-1 polypeptide with an N-terminal amino acid extension and a protractor wherein the amino acid extension comprises 3 to 36 amino acid residues and where the MIC-1 polypeptide and the N-terminal amino acid extension together have a calculated pI lower than 6.5. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds.
Soft Copy Attached in PDF
| # | Name | Date |
|---|---|---|
| 1 | 201947049426.pdf | 2019-12-02 |
| 2 | 201947049426-STATEMENT OF UNDERTAKING (FORM 3) [02-12-2019(online)].pdf | 2019-12-02 |
| 3 | 201947049426-SEQUENCE LISTING(PDF) [02-12-2019(online)].pdf | 2019-12-02 |
| 4 | 201947049426-SEQUENCE LISTING [02-12-2019(online)].txt | 2019-12-02 |
| 5 | 201947049426-PRIORITY DOCUMENTS [02-12-2019(online)].pdf | 2019-12-02 |
| 6 | 201947049426-POWER OF AUTHORITY [02-12-2019(online)].pdf | 2019-12-02 |
| 7 | 201947049426-FORM 18 [02-12-2019(online)].pdf | 2019-12-02 |
| 8 | 201947049426-FORM 1 [02-12-2019(online)].pdf | 2019-12-02 |
| 9 | 201947049426-DRAWINGS [02-12-2019(online)].pdf | 2019-12-02 |
| 10 | 201947049426-DECLARATION OF INVENTORSHIP (FORM 5) [02-12-2019(online)].pdf | 2019-12-02 |
| 11 | 201947049426-COMPLETE SPECIFICATION [02-12-2019(online)].pdf | 2019-12-02 |
| 12 | Correspondence by Agent_Sequence Listing_05-12-2019.pdf | 2019-12-05 |
| 13 | 201947049426-Proof of Right [01-06-2020(online)].pdf | 2020-06-01 |
| 14 | 201947049426-FORM 3 [01-06-2020(online)].pdf | 2020-06-01 |
| 15 | 201947049426-FORM 3 [27-11-2020(online)].pdf | 2020-11-27 |
| 16 | 201947049426-FORM 3 [27-05-2021(online)].pdf | 2021-05-27 |
| 17 | 201947049426-FORM 3 [16-11-2021(online)].pdf | 2021-11-16 |
| 18 | 201947049426-FORM 3 [10-05-2022(online)].pdf | 2022-05-10 |
| 19 | 201947049426-FER.pdf | 2022-08-02 |
| 20 | 201947049426-Information under section 8(2) [28-10-2022(online)].pdf | 2022-10-28 |
| 21 | 201947049426-FORM 3 [28-10-2022(online)].pdf | 2022-10-28 |
| 22 | 201947049426-RELEVANT DOCUMENTS [30-11-2022(online)].pdf | 2022-11-30 |
| 1 | strategy_49246E_01-08-2022.pdf |